Negative aspects of weight loss pills: How DNA analysis can offer a safe alternative.

A recent discussion on weight loss drugs such as semaglutide shows impressive weight losses of up to 16%, but there are also negative aspects, such as increased risks of gastrointestinal problems and uncertain long-term effects. These concerns reinforce the desire for more individualized approaches, such as DNA-based analysis that takes genetic factors into account and creates personalized diet and exercise plans. Studies suggest that people often achieve more sustainable and safer results through genetically tailored programs than through standardized drug treatments.

Scientists like Rubino et al.